3 Ways Big Data and Machine Learning Revolutionize Drug Discovery
The Internet media is trending now with numerous mentions of “big data”, “machine learning” and “artificial intelligence” all together destined …
All Posts
New Study Shows Remdesivir Prevents Coronavirus MERS-CoV Infection In Monkeys
In a new study, researchers from the National Institutes of Health reported that the experimental antiviral drug remdesivir (also known as …
How Pharma Reacts To Wuhan Coronavirus Outbreak
UPDATE April 04. 2020. The number of confirmed cases of COVID19 approaches 1M globally. Since too many drug repurposing programs …
Top Companies At The Forefront Of RNA Therapeutics Development
Alongside the topic of gene editing technologies that keeps making headlines these days, there is also a wave of breakthroughs …
C2 PHARMA Expands Advisory Board To Support Growth Objectives
Luxembourg, March 3, 2020 – C2 PHARMA s.a.r.l. (C2P), a Luxembourg-based phytochemical and chemical pharmaceutical manufacturing and distribution group, has …
Structural Basis of Poxvirus Transcription Revealed
In order for viruses to proliferate, they usually need to be supported by infected cells. In many cases, the molecules …
This Discovery Of Immune Cells May Start The Development Of New Anti-cancer Therapies
Recently, in research published in the Immunity, researchers from University College London in the United Kingdom revealed that a special …
Paving A Pathway To Pharma 4.0
Pharmaceutical manufacturers find themselves at a critical juncture. In the past 30 years, pharma has seen some significant shifts. Consider …
A Race For Better Gene Editing Tech Is On
A transformative technology for gene editing - clustered regularly interspaced short palindromic repeats (CRISPR) -- has become ubiquitous, at least …
AI For Commercial Life Sciences: 3 Trends You Can’t Ignore In 2020
As we enter a new decade, our belief in the the impact of Artificial intelligence (AI) is only getting stronger. …
The Evolving Pharma R&D Outsourcing Industry: A Bird’s-eye View
Pharmaceutical companies are increasingly outsourcing their R&D activities, including early-stage research programs, to third party organizations -- academic institutions, biotech …
The Promise Of Cell Technologies In Immunotherapy
The number of immunotherapies in clinical trial rolls over 5000 now, and immunology has become a common approach in some …
